Biocon elevates M B Chinappa as CFO of biosimilar subsidiary

M B Chinappa, who is going to play an important role in Biocon Biologics’ journey towards becoming a global leader in biologics, has been tasked to drive financial performance of the company and improve profitability and manage anticipated risks in the journey of achieving the $1 billion revenue target in FY22, said the company in a press release.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2tChXNO
via IFTTT